Platforms
Our modular ADC platforms are generating potential first and best in class assets, including novel proprietary payloads, advanced masking technologies, and linker and drug conjugation strategies.
Pipeline
Our proprietary pipeline of precision-built ADCs reflects our expertise in research, lead identification, preclinical and clinical development, process development, and manufacturing.
Publications & Presentations
Novel developments are regularly published in highly ranked peer-reviewed journals.
Partnering
Our modular approach to ADC design enables partnering flexibility, with strategic collaborations tailored to deliver maximum value for patients and partners.
Press Releases
Stay up to date with the latest news from Byondis, including company milestones, clinical progress, and partnership announcements. Our press releases reflect our commitment to advancing innovative targeted medicines for people living with cancer.
